Concerning the inhibitory receptor repertoire of NK effectors in the CLL cohort, a significant down-modulation of 3DL1 and NKG2A [75,76,77] inhibitory molecules was revealed, while an increased level of the HLA-G binding CD85k receptor was observed [67,68]. Here, KLRC1 is linked to B-cell chronic lymphocytic leukemia.